BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9070314)

  • 1. Tissue-specific and growth-regulated expression of CD44 variable exon determinants in the mouse.
    Yamashita Y; Hirano H; Hodes RJ
    Cell Immunol; 1997 Feb; 176(1):22-33. PubMed ID: 9070314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
    Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural variability of CD44v molecules and reliability of immunodetection of CD44 isoforms using mAbs specific for CD44 variant exon products.
    Martegani MP; Del Prete F; Gasbarri A; Natali PG; Bartolazzi A
    Am J Pathol; 1999 Jan; 154(1):291-300. PubMed ID: 9916943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines.
    Stickeler E; Runnebaum IB; Möbus VJ; Kieback DG; Kreienberg R
    Anticancer Res; 1997; 17(3C):1871-6. PubMed ID: 9216637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.
    Fox SB; Fawcett J; Jackson DG; Collins I; Gatter KC; Harris AL; Gearing A; Simmons DL
    Cancer Res; 1994 Aug; 54(16):4539-46. PubMed ID: 7519124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma.
    Ermak G; Jennings T; Robinson L; Ross JS; Figge J
    Cancer Res; 1996 Mar; 56(5):1037-42. PubMed ID: 8640758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans-acting factors regulate the expression of CD44 splice variants.
    Konig H; Moll J; Ponta H; Herrlich P
    EMBO J; 1996 Aug; 15(15):4030-9. PubMed ID: 8670907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zymosan modulates CD44 isoform expression in a murine model of inflammation resembling rheumatoid arthritis synovitis.
    Cabrera PV; Blanco G; Gravisaco MJ; Alvarez E; Hajos S
    J Rheumatol; 2001 May; 28(5):943-9. PubMed ID: 11361220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of human articular chondrocyte CD44 isoform expression and function in health and disease.
    Salter DM; Godolphin JL; Gourlay MS; Lawson MF; Hughes DE; Dunne E
    J Pathol; 1996 Aug; 179(4):396-402. PubMed ID: 8869287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells.
    Soukka T; Salmi M; Joensuu H; Häkkinen L; Sointu P; Koulu L; Kalimo K; Klemi P; Grénman R; Jalkanen S
    Cancer Res; 1997 Jun; 57(11):2281-9. PubMed ID: 9187133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel transmembrane GTPase of non-small cell lung cancer identified by mRNA differential display.
    Chung JG; Yeh KT; Wu SL; Hsu NY; Chen GW; Yeh YW; Ho HC
    Cancer Res; 2001 Dec; 61(24):8873-9. PubMed ID: 11751411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in CD44 isoform expression during inflammatory skin disease.
    Harris AJ; Dean D; Burge S; Wojnarowska F
    Clin Exp Dermatol; 1997 May; 22(3):128-33. PubMed ID: 9425692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.
    Fichtner I; Dehmel A; Naundorf H; Finke LH
    Anticancer Res; 1997; 17(5A):3633-45. PubMed ID: 9413216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD44 and variant isoforms in cultured human retinal pigment epithelial cells.
    Liu NP; Roberts WL; Hale LP; Levesque MC; Patel DD; Lu CL; Jaffe GJ
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2027-37. PubMed ID: 9331266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
    Abetamann V; Kern HF; Elsässer HP
    Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD44 variant isoforms in malignant melanoma.
    Seiter S; Schadendorf D; Herrmann K; Schneider M; Rösel M; Arch R; Tilgen W; Zöller M
    Clin Cancer Res; 1996 Mar; 2(3):447-56. PubMed ID: 9816190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel splice variants of the human CD44 gene.
    Vela E; Roca X; Isamat M
    Biochem Biophys Res Commun; 2006 Apr; 343(1):167-70. PubMed ID: 16530165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.
    Boldrup L; Coates PJ; Gu X; Nylander K
    J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of hormones on CD44 expression in endometrial and breast carcinomas.
    Durst B; Sorg RV; Röder G; Betz B; Beckmann MW; Niederacher D; Bender HG; Dall P
    Oncol Rep; 2001; 8(5):987-93. PubMed ID: 11496303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternatively spliced CD44 isoforms containing exon v10 promote cellular adhesion through the recognition of chondroitin sulfate-modified CD44.
    Chiu RK; Droll A; Dougherty ST; Carpenito C; Cooper DL; Dougherty GJ
    Exp Cell Res; 1999 Apr; 248(1):314-21. PubMed ID: 10094837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.